Samsung Biologics
207940.KS
#399
Rank
โ‚น4.462 T
Marketcap
โ‚น62,698
Share price
-0.19%
Change (1 day)
20.22%
Change (1 year)

Earnings for Samsung Biologics (207940.KS)

Earnings in 2024 (TTM): โ‚น86.44 Billion

According to Samsung Biologics 's latest financial reports the company's current earnings are โ‚น3.30 Billion. , an increase over its 2023 earnings that were of โ‚น78.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Samsung Biologics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 โ‚น88.04 B12.65%
2023 โ‚น78.15 B9.77%
2022 โ‚น71.20 B67.66%
2021 โ‚น42.46 B103.97%
2020 โ‚น20.82 B57.39%
2019 โ‚น13.22 B-45.46%
2018 โ‚น24.25 B-390%
2017 -โ‚น8.37 Billion-46.74%
2016 -โ‚น15.71 Billion